Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Ophthalmology. 2011 Jan;118(1):77-81. doi: 10.1016/j.ophtha.2010.04.033. Epub 2010 Aug 14.
To report the initial clinical outcomes of a combined procedure utilizing 25-gauge vitrectomy and posterior tube shunt placement in eyes with refractory glaucoma not amenable to standard treatment.
Retrospective chart review.
We included 10 eyes (10 consecutive adult patients, mean age 61 years) with advanced glaucoma and anterior segment abnormalities precluding tube placement in the anterior chamber who were treated with combined 25-gauge vitrectomy and posterior tube shunt placement.
Records of consecutive patients were reviewed for demographics, etiology of glaucoma, preoperative clinical data (visual acuity, intraocular pressure, number of ocular antihypertensive medications), and postoperative outcome measures at predetermined time points.
(1) Intraocular pressure (IOP) at 1, 2, 6, and 12 months postoperatively; (2) number of ocular antihypertensive medications needed at 12 months postoperatively; (3) visual acuity (VA) at 12 months postoperatively; and (4) incidence of hypotony, retinal detachment, endophthalmitis, and corneal decompensation.
Preoperatively, mean IOP was 31 mmHg, and patients required a mean of 2.5 ocular antihypertensive medications. Mean IOP at 1, 2, 6, and 12 months postoperatively were 17.0, 16.1, 17.8, and 16.1 mmHg, respectively, and significantly lower than preoperative IOP (P < 0.005 at all time points). At 1 year postoperatively, 90% of patients had an IOP < 20 mmHg, and 50% of patients required ≤ 2 ocular antihypertensive medications. At 1 year postoperatively, VA was the same or improved in 70% of patients, and no worse than 1 Snellen line in any patient. Corneal edema developed in 2 patients. No patient developed hypotony or endophthalmitis.
Combined 25-gauge vitrectomy and posterior tube shunt placement can be successful in lowering IOP in eyes with advanced glaucoma not amenable to other therapies.
报告联合 25G 玻璃体切除术和后房引流管植入术治疗难治性青光眼的初步临床结果,这些青光眼对标准治疗无效且伴有眼前段异常,无法在前房植入引流管。
回顾性病例系列。
我们纳入了 10 只眼(10 例连续成年患者,平均年龄 61 岁),这些眼患有晚期青光眼且伴有眼前段异常,无法在前房植入引流管,采用联合 25G 玻璃体切除术和后房引流管植入术进行治疗。
回顾性分析连续患者的病历资料,包括人口统计学信息、青光眼病因、术前临床数据(视力、眼压、降眼压药物的使用次数)和预定时间点的术后结果。
(1)术后 1、2、6 和 12 个月的眼压;(2)术后 12 个月时所需降眼压药物的数量;(3)术后 12 个月的视力;(4)低眼压、视网膜脱离、眼内炎和角膜失代偿的发生率。
术前平均眼压为 31mmHg,患者平均使用 2.5 种降眼压药物。术后 1、2、6 和 12 个月的平均眼压分别为 17.0、16.1、17.8 和 16.1mmHg,与术前眼压相比均显著降低(所有时间点 P<0.005)。术后 1 年时,90%的患者眼压<20mmHg,50%的患者需要使用≤2 种降眼压药物。术后 1 年时,70%的患者视力保持或提高,且无任何患者视力下降超过 1 行。2 例患者出现角膜水肿。无患者发生低眼压或眼内炎。
联合 25G 玻璃体切除术和后房引流管植入术可以成功降低其他治疗方法无效的晚期青光眼的眼压。